Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- Check4 days agoChange DetectedThe recurrent glioblastoma trial record is now displayed, including its terminated status, study design, eligibility criteria, outcomes, and study documents.SummaryDifference58%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision identifier updates from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page for the trial now displays a 403 Forbidden error, removing the previous study content and contacts and leaving only site chrome and the error message.SummaryDifference20%

- Check60 days agoChange DetectedFooter revision label updated from v3.6.6 to v3.7.0, indicating a CMS update; no study text or page content appears to be affected.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.